Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Fast Breaking Comments

By Mark P. Mattson

ESI Special Topics, August 2005
Citing URL - http://www.esi-topics.com/fbp/2005/august05-MarkPMattson.html

Mark P. Mattson answers a few questions about this month's fast breaking paper in the field of Neuroscience & Behavior.


From •>>August 2005  

Field: Neuroscience & Behavior
Article Title: Pathways towards and away from Alzheimer's disease
Authors: Mattson, MP
Journal: NATURE
Volume: 430
Page: 631-639
Year: AUG 5 2004
* NIA, Neurosci Lab, Intramural Res Program, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
* NIA, Neurosci Lab, Intramural Res Program, Baltimore, MD 21224 USA.
* Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.

ST:  Why do you think your paper is highly cited?


My review article provides food for thought and action for scientists and clinicians interested in AD.”

Alzheimer's disease (AD) is a devastating age-related disorder of progressive memory impairment and behavioral disturbances that exacts a toll not only on the patient, but also on his/her family and friends. Rapid advances on multiple fronts—genetics, cell and molecular biology, brain imaging, and epidemiology, among others—have revealed some of the major abnormalities that result in the dysfunction of synapses and the death of neurons in AD. This paper is highly cited because it is a review article that describes the current state of knowledge of the cellular and molecular mechanisms of AD in the context of genes, aging, and the environment. I attempted to write the article so that it was concise and readable, yet inclusive of a range of findings and issues concerning the cellular and molecular mechanisms of neuronal dysfunction and death in AD, and preventative and therapeutic approaches that have/will emerge from this research. The history of AD research is a wonderful example of how studying a disease can reveal previously unrecognized physiological mechanisms, with the story of the secretases that cleave the amyloid precursor protein and Notch1 being a prime example. Human Notch1 is a modular, single-pass transmembrane receptor that normally controls cellular differentiation in hematopoetic including neurons. The complexity of this disease encompasses an increasing number of disciplines, including free-radical biology, regulation of cellular ion homeostasis and energy metabolism, and immunology. My review article provides food for thought and action for scientists and clinicians interested in AD.

ST:  How did you become involved in this research?

A series of developments in my research projects in developmental neurobiology when I was a postdoc eventually led to a strong interest in AD. At that time my colleagues and I were providing evidence that neurotransmitters not only function in synaptic transmission in the mature nervous system, but also regulate the outgrowth and survival of neurons in the developing brain. I had found that the neurotransmitter glutamate regulates dendrite outgrowth and synaptogenesis in the developing hippocampus (a brain region involved in learning and memory and vulnerable in AD). However, excessive activation of glutamate receptors could kill neurons, causing some changes in the cytoskeleton of neurons that are similar to those seen in dying neurons in the brains of AD patients. This led me to explore the effects of amyloid beta-peptide (which forms amyloid plaques in the brain in AD) on neurons, demonstrating toxic effects mediated by oxidative stress and an impaired ability to regulate calcium levels. We further showed that several different neurotrophic factors can protect neurons from being damaged and killed by glutamate and amyloid, and have been particularly interested in elucidating signaling pathways that can prevent amyloid production and deposition in the brain on the one hand, and those that can protect neurons from being damaged by amyloid on the other hand. This research has contributed to the development of novel preventative and therapeutic strategies for AD, including diets and drugs that protect neurons against the damaging effects of glutamate and amyloid.End

Mark P. Mattson, Ph.D.
Chief of the Laboratory of Neurosciences
Cellular and Molecular Neurosciences Section
National Institute on Aging Intramural Research Program
Gerontology Research Center
Baltimore, MD, USA


ESI Special Topics, August 2005
Citing URL - http://www.esi-topics.com/fbp/2005/august05-MarkPMattson.html

•> Search Special Topics
Fast Breaking Papers Menu || All Topics Menu
Fast Breaking Papers Comments Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.